Zhang, Z., Rao, C., Hu, M., Yan, W., & Du, Z. (2025). Highly expressed GCN1 is associated with cancer progression and poor prognosis in hepatocellular carcinoma patients. Cancer Cell International, 25(1), 1. https://doi.org/10.1186/s12935-025-03732-y
Chicago Style (17th ed.) CitationZhang, Zhongchao, Caijun Rao, Mingcun Hu, Wei Yan, and Zhipeng Du. "Highly Expressed GCN1 Is Associated with Cancer Progression and Poor Prognosis in Hepatocellular Carcinoma Patients." Cancer Cell International 25, no. 1 (2025): 1. https://doi.org/10.1186/s12935-025-03732-y.
MLA (9th ed.) CitationZhang, Zhongchao, et al. "Highly Expressed GCN1 Is Associated with Cancer Progression and Poor Prognosis in Hepatocellular Carcinoma Patients." Cancer Cell International, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12935-025-03732-y.